Literature DB >> 1356916

CD26 induces T-cell proliferation by tyrosine protein phosphorylation.

E Muñoz1, M V Blazquez, J A Madueño, G Rubio, J Peña.   

Abstract

CD26 antigen distribution among lymphoid cells and its participation in the process of lymphocyte activation and proliferation has been widely documented. However, the molecular and biochemical mechanisms coupled to the CD26 molecule are not yet known. With different monoclonal antibodies (mAb) we have detected that approximately 56% of CD4+ and 35% of CD8+ cells from peripheral blood lymphocytes express CD26 and the expression of this antigen is required for antigen- but not for mitogen-induced proliferation unless exogenous interleukin-2 (IL-2) is added to the culture. The stimulation of nylon wool-separated T cells and T-cell clones by the anti-CD26 mAb, 134-2C2, induced tyrosine phosphorylation on a subset of proteins of 50,000, 46,000, 26,000, 24,000 and 21,000 MW. This pattern of phosphorylation was not affected by the presence of 12-myristate 13-acetate (PMA), although this cofactor is required for CD26-mediated IL-2 mRNA expression and T-cell proliferation. When a specific tyrosine kinase inhibitor, Tyrphostin, was used in CD4+ cells cultures stimulated with 134-2C2 and PMA, the proliferation and the expression of IL-2 mRNA were inhibited. Thus, protein tyrosine phosphorylation seems to play a major role in CD26-mediated T-cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356916      PMCID: PMC1421601     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

Review 1.  T-cell development and transmembrane signaling: changing biological responses through an unchanging receptor.

Authors:  T H Finkel; R T Kubo; J C Cambier
Journal:  Immunol Today       Date:  1991-02

2.  Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor.

Authors:  L E Samelson; M D Patel; A M Weissman; J B Harford; R D Klausner
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

3.  Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.

Authors:  N H Dang; Y Torimoto; K Sugita; J F Daley; P Schow; C Prado; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

4.  The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity.

Authors:  M Hegen; G Niedobitek; C E Klein; H Stein; B Fleischer
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

5.  T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation.

Authors:  T Mustelin; K M Coggeshall; N Isakov; A Altman
Journal:  Science       Date:  1990-03-30       Impact factor: 47.728

6.  1F7, a novel cell surface molecule, involved in helper function of CD4 cells.

Authors:  C Morimoto; Y Torimoto; G Levinson; C E Rudd; M Schrieber; N H Dang; N L Letvin; S F Schlossman
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

7.  Tyrosine phosphorylation is an obligatory event in IL-2 secretion.

Authors:  J B Stanley; R Gorczynski; C K Huang; J Love; G B Mills
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

8.  Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.

Authors:  A E Nel; C Hanekom; A Rheeder; K Williams; S Pollack; R Katz; G E Landreth
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

9.  Intimate association of Thy-1 and the T-cell antigen receptor with the CD45 tyrosine phosphatase.

Authors:  S Volarević; C M Burns; J J Sussman; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

10.  Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family.

Authors:  N H Dang; Y Torimoto; S F Schlossman; C Morimoto
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  4 in total

1.  Antibody-induced modulation of CD26 surface expression.

Authors:  T Mattern; C Reich; M Duchrow; S Ansorge; A J Ulmer; H D Flad
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

2.  Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis.

Authors:  Kirsten Schulz; Jana Frahm; Susanne Kersten; Ulrich Meyer; Jürgen Rehage; Marion Piechotta; Maria Meyerholz; Gerhard Breves; Dania Reiche; Helga Sauerwein; Sven Dänicke
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

Review 3.  Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical Trials.

Authors:  Jixin Zhong; Quan Gong; Aditya Goud; Srividya Srinivasamaharaj; Sanjay Rajagopalan
Journal:  J Diabetes Res       Date:  2015-05-14       Impact factor: 4.011

4.  Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.

Authors:  Kalpit A Vora; Gene Porter; Roche Peng; Yan Cui; Kellyann Pryor; George Eiermann; Dennis M Zaller
Journal:  BMC Immunol       Date:  2009-04-09       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.